We know the time is short and that we need to take initiative in a timely manner. We are in the process of assessing the best options for maximal impact. Some of the strategies may require action by masses to have the maximal impact. I will keep the board updated in these initiatives and if we require your participation. We have several important initiatives planned for the immediate future which I will update as it happens.
I will also suggest what we might be able to do with the combining of the shares for a united action.
Please feel free to contact me at speedrunner199atyahoodotcom.
Final share count 11/4/2013:
The total share count is 5,114,103.
I want to thank everyone for sharing their share count with me and for your willingness to participate in a unified front for a common goal. I am also thankful to all of you who have shared your compelling stories. Most of us have suffered great losses so far. It certainly has been a nightmarish scenario. However, all is not lost yet. Bottom-line is, vascepa appears to be a great drug and, so far, the data from Marin and Anchor clinical trials have been excellent. There is also compelling reason to believe that Reduce-It outcome study will demonstrate positive clinical outcome.
FDA’s review had major flaws and the rescinding of the SPA based on the 3 poorly designed outcome studies lacks justification. However, this is the situation we find ourselves in. It is clearly an uphill battle to reverse FDA’s position but a battle that we may be able to win. We have to fight this injustice.
There are number of shareholders (with excellent qualifications) that have come together to lead the fight against FDA’s unjustified rescinding of the SPA. There are several initiatives being taken by the group to organize the fight against FDA’s ruling. A web-site has been launched that has compiled many important dinfo related to vascepa including the FDA panel meeting info. Please visit epadruginitiativedotcom. Additionally, a letter campaign is being initiated to congressional oversight committee that overlooks FDA, direct letter writing campaign to FDA director and leaders, contacting news organizations, and initiatives for media release. We are also in the process of organizing other responses that will maximally pressure FDA to reverse their position. cont.
8:00 PM mountain time.
The total count reported to me is 4,823,749. The total count is very impressive.
I will continue the share count for 1 more day. Once I have the complete share count, I will then propose how we may affect influence on AMRN and would also welcome suggestions from the MB.
I want to thank everyone for sharing their share counts with me and for joining in to participate in a unified front for a common goal. I am also grateful to those who have shared their compelling stories- it is very touching.
I am aware of number of initiatives that are in motion including a formation of a dedicated website on vascepa - now up and running, a letter being submitted FDA oversight sub-committee, contacting major media outlets, letter writing to FDA, major medical organizations and cardiologists. Some of this activities will be completed within next few days. Many individuals have selflessly devoted many hours and days to support vascepa approval and moving things forward. I would like acknowledge Zumantu for leading this effort and for all those who are contributing their time and effort in advancing vascepa usage and AMRN success and taking on the fight to FDA.
Please feel free to suggest any great ideas to make an impact on this message board or email me.
I will provide additional updates on actions taken and provide copy of submitted letters and ask for help when warranted.
I also apologize for not responding to comments by the posters, I have been pre-occupied with the share count and working on other initiatives in progress. Once this is completed, I will answer questions or comments.
Up to now 7:45 PM mountain time, I have total of 3,000,025 shares reported to me. I will continue the share count for 2 more days. Depending on the share count, I will then propose how we may affect influence on AMRN and would also welcome suggestions from the MB. Of course, higher the count the better.
I also want to thank everyone for sharing their share counts with me and for your willingness to participate in a unified front for a common goal. I also want to thank those who have shared their compelling stories and losses. I am aware of several initiatives that are in motion including a formation of a dedicated website, a letter being submitted FDA oversight sub-committee, contacting major media outlets, letter writing to FDA, major medical organizations and cardiologists. Some of this activities will be completed within next few days. Other possibilities that are likely to have major impact are also being considered (including legal action- although this does not appeared to be a good option)- all reasonable options are being considered. Please feel free to suggest any great ideas to make an impact.
I will provide additional updates on actions taken and provide copy of submitted letters and ask for help when warranted. We clearly want to have as much of an impact as possible- a major target will be the print media.
Again, thank you for your participation.
Great work. We have a group organized in place that is working on major responses and have many available info by many hard working individuals. Please e-mail me at speedrunner199at yahoodotcom for help. I will link you the Zumantu and others who are actively working on this.
I will help you anyway I can.
I agree with your list but there are additional possibilities:
1. They could stop selling vascepa and either contract or partner out vascepa sales to another company for a small royalty. That way they don't have to spend any money on sales and collect small royalty and use the 200 million to complete the Reduce It study.
2. Partner Reduce It to BP for split in future sales or royalty. This allows Reduce It to be completed. Partner would stand to lose 200 million for the study but could gain a $10 billion/yr drug for a small rsik.
3. Buy out is possible for a small upfront fee (.5 to 1.5 bill) and conditional payment of 4 bill if Reduce It is positive. BP can't lose on this type of deal. They can easily reach $500 mill in sales and have potential for a 10 bill drug.
I would like to thank everyone for sharing their share count and willing to form a united share representation group. I am also touched by the e-mails that were sent and the pain that everyone has suffered. Some have lost millions, others lesser amounts but the loss has been deeply felt by all.
I have been in touch with zumantu and 23 other investors that have formed a group to form a unified response group. Zumantu is leading the effort and firmly committed to fighting this fight. Several initiatives are in the works and several others being considered. I would encourage any good ideas and would invite individuals with special expertise to join. We have several MDs and many talented individuals but we have a great need for individuals with law background and corporate background.
I am firmly committed to AMRN cause and believe in vascepa data and seeing through the Reduce It data.
I intend to initiate discussions on AMRN valuation and prospects going forward so that everyone can be better informed and make a rational investment decision. I think it would also be valuable for everyone to have an in-depth discussion on the science of vascepa and the likelihood for success based on scientific data. This is my strong suit and will be happy to share in this analysis. I think it would be constructive to look at the AMRN prospective in a level-headed manner without emotion.
The share count so far is 1,771,543.
Please provide me with your share amount if you are interested in a unified investor group to affect a
change or having a unified front. The more share we have, the more likelihood that we will be taken seriously.
We are in the process of oranizing a unified, organized AMRN share holder response group in IHUB. I am obtaining a share count so that we may have better representation when dealing with AMRN management. I will be reportingthe share holder counts every evening. Can you please post how many shares that you own. You can also e-mail me privately at speedrunner199at yahoo- All private information will be kept strictly confidential. My best estimate is that we have several million shares being held by the posters.
Anyone interested in participating or contributing to the response process can also contact zumatu at gmail- he is leading the effort.